[Newly occurring loss of visual acuity in choroidal osteoma].
Approach to loss of visual acuity in a patient with a choroidal osteoma (CO) which had been stable for seven years. Fluorescence angiography confirmed a choroidal neovascularization (CNV) as the cause of the loss of visual acuity. Treatment with intravitreal (IVT) injection of ranibizumab. Increase of visual acuity and decrease of edema after IVT injection. Monitoring is necessary even for primarily benign CO in order to detect secondary complications causing loss of visual acuity, e. g. secondary CNV. Anti-VEGF IVT represents an approved treatment option.